Assessing placebo effects without placebo groups: An untapped possibility?

Pain

Volumn 90, Issue 3, 2001, Pages 201-203

  Price, Donald D ^a,b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PLACEBO;

ALTERNATIVE MEDICINE; ANALGESIA; ANALGESIC ACTIVITY; DRUG EFFICACY; EDITORIAL; FEASIBILITY STUDY; HUMAN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

HUMANS; PAIN; PLACEBO EFFECT; PLACEBOS;

EID: 0035864992     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00265-2     Document Type: Editorial

References (16)

1. Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems
2. The powerful placebo
3. Somatotopic activation of opioid systems by target-directed expectations of analgesia
4. Toward a neurobiology of placebo analgesia
5. Placebo and naloxone can alter postsurgical pain by separate mechanisms
6. Partial antagonism of placebo analgesia by naloxone
7. Motivation and expectancy factors in symptom perception: A laboratory study of the placebo effect
8. The mechanism of placebo analgesia
9. Classical conditioning and the placebo effect
10. Where are the causes of placebo analgesia? An experiential behavioral analysis
11. A psychophysical analysis of morphine analgesia
12. A simultaneous comparison of fentanyl's analgesic effects on experimental and clinical pain
13. An analysis of factors that contribute to the magnitude of placebo analgesia
14. The importance of placebo effects in pain treatment and research
15. The placebo and the placebo response